The Santa Clara, California-based medical devices company said its second-quarter profit, on an adjusted basis, rose to $1.27 per share from $1.13 per share in the year-ago period.
Unadjusted net income moved up to $302 million or $1.02 per share from $274 million or $0.91 per share in the corresponding quarter of 2022. At $1.72 billion, revenues were up 7% from last year.
“Revenues of $1.72 billion are up 9.5 percent core with growth across all end markets and regions. Our results are driven by an innovative and broad portfolio, a differentiated customer experience, and outstanding execution,” said Agilent’s CEO Mike McMullen.
ADVERTISEMENT
